Latest Climate Change News

Oceania Healthcare has modernized its property portfolio and updated its dividend policy to align with a new strategic direction under CEO Suzanne Dvorak, aiming to meet New Zealand's growing aged care demand.

ALS Limited reported a robust FY25 with 16% revenue growth to AUD 3 billion, underpinned by strong organic expansion and key acquisitions. Despite slight NPAT decline, the company advances its sustainability agenda and invests in global lab upgrades.

Munro Climate Change Leaders Fund Active ETF (ASX – MCCL) has released an estimated cash distribution of 302.3 cents per unit for the fiscal year ending 30 June 2025, signaling investor returns amid evolving market conditions.

ACDC Metals has lodged a retention licence application for its Goschen Central project in Victoria, marking a pivotal step in developing a critical minerals supply hub with strong economic prospects.

Capricorn Metals has extended its mining contract with MACA Ltd for Karlawinda and named MACA preferred contractor for Mt Gibson, locking in cost certainty and supporting production growth.

Bastion Minerals Limited has announced a non-renounceable pro-rata rights issue to raise approximately $677,721 at a 50% discount to the last trading price. The funds will support ongoing project evaluation and working capital needs.

RLF AgTech has secured exclusive rights to distribute AXIOMA Biologicals’ advanced biostimulant products across Australia, China, and Asia, marking a strategic move into the biologicals market segment.

ALS Limited reported a 16% revenue increase to nearly $3 billion in FY2025, driven by acquisitions and organic growth, while underlying net profit after tax dipped slightly. The company announced a $350 million equity raise to fund expansion and sustainability initiatives.

Zeotech Limited has successfully completed a two-year methane control program, developing a zeolite-based biofilter that reduces landfill methane emissions by more than 90%. The company is now preparing for on-site trials and commercial deployment.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.

Triangle Energy reported a $9.85 million cash balance for the March quarter, plugged the Becos-1 well after disappointing results, and agreed to defer the Cliff Head asset sale to Pilot Energy until 2026.

Sprintex Limited has advanced its commercial and technological milestones with major European and Indian orders, breakthrough energy efficiency validation, and a successful A$3.25 million equity raise, positioning the company for accelerated growth.